製品: SLFN14 Antibody
カタログ: DF13579
タンパク質の説明: Rabbit polyclonal antibody to SLFN14
アプリケーション: ELISA(peptide)
Cited expt.:
反応性: Human
予測: Horse, Rabbit
分子量: 103kDa(Observed); 104kD(Calculated).
ユニプロット: P0C7P3
RRID: AB_2846598

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
反応性:
Human
予測:
Horse(100%), Rabbit(%)
クローナリティ:
Polyclonal
特異性:
SLFN14 Antibody detects endogenous levels of total SLFN14.
RRID:
AB_2846598
引用形式: Affinity Biosciences Cat# DF13579, RRID:AB_2846598.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

Schlafen family member 14; SLFN14; SLN14_HUMAN;

免疫原

免疫原:

A synthesized peptide derived from human SLFN14, corresponding to a region within C-terminal amino acids.

Uniprot:
遺伝子(ID):
発現特異性:
P0C7P3 SLN14_HUMAN:

Expressed in megakaryocytes and platelets (at protein level) (PubMed:26280575). Weakly expressed in melanocytes and malignant melanoma cells (PubMed:20956525).

タンパク質配列:
MESLKTDTEMPYPEVIVDVGRVIFGEENRKKMTNSCLKRSENSRIIRAICALLNSGGGVIKAEIDDKTYSYQCHGLGQDLETSFQKLLPSGSQKYLDYMQQGHNLLIFVKSWSPDVFSLPLRICSLRSNLYRRDVTSAINLSASSALELLREKGFRAQRGRPRVKKLHPQQVLNRCIQEEEDMRILASEFFKKDKLMYKEKLNFTESTHVEFKRFTTKKVIPRIKEMLPHYVSAFANTQGGYVLIGVDDKSKEVVGCKWEKVNPDLLKKEIENCIEKLPTFHFCCEKPKVNFTTKILNVYQKDVLDGYVCVIQVEPFCCVVFAEAPDSWIMKDNSVTRLTAEQWVVMMLDTQSAPPSLVTDYNSCLISSASSARKSPGYPIKVHKFKEALQRHLFPVTQEEVQFKPESLCKKLFSDHKELEGLMKTLIHPCSQGIVIFSRSWAGDVGFRKEQNVLCDALLIAVNSPVVLYTILIDPNWPGGLEYARNTAHQLKQKLQTVGGYTGKVCIIPRLIHLSSTQSRPGEIPLRYPRSYRLADEEEMEDLLQALVVVSLSSRSLLSDQMGCEFFNLLIMEQSQLLSESLQKTRELFIYCFPGVRKTALAIKIMEKIKDLFHCKPKEILYVCESDSLKDFVTQQTTCQAVTRKTFMQGEFLKIKHIVMDETENFCSKYGNWYMKAKNITHPKAKGTGSENLHHGILWLFLDPFQIHHADVNGLPPPSAQFPRKTITSGIHCALEIAKVMKEEMKRIKENPPSNMSPDTLALFSETAYEEATCAQALPGVCETKTNLTTEQIANYVARKCHSLFQCGYLPKDIAILCRRGEDRGRYRLALLKAMELIETHRPSEVVFSPATGVWGSHIVLDSIQQFSGLERTVVFGLSPECDQSEEFHKLCFASRAIKHLYLLYEKRAAY

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Rabbit
100
Horse
100
Pig
75
Dog
63
Bovine
0
Sheep
0
Xenopus
0
Zebrafish
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

研究背景

機能:

Shows no ribosome-associated and endoribonuclease activities.

Displays polysome-associated endoribonuclease activity towards mRNAs and rRNAs. May play a role in RNA surveillance pathways by recognizing stalled ribosomes and triggering endonucleolytic cleavage of aberrant mRNAs (Probable). Cleaves different types of rRNAs and mRNAs in a magnesium- and manganese-dependent and ATP-independent manner (By similarity). Involved in correct maturation of megakaryocytes and especially important for proplatelet extension.

細胞の位置付け:

Nucleus.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Expressed in megakaryocytes and platelets (at protein level). Weakly expressed in melanocytes and malignant melanoma cells.

タンパク質ファミリー:

Belongs to the Schlafen family. Subgroup III subfamily.

参考文献

1). Novel mutation SLFN14 T853fs associated with inherited macrothrombocytopenia. Molecular therapy. Nucleic acids, 2025 (PubMed: 40510593) [IF=6.5]

Application: WB    Species: human    Sample:

Figure 3 T853fs leads to low expression level of SLFN14 (A and B) HEK293T and Meg-01 cells were transfected with SLFN14-WT or SLFN14-T853fs overexpression plasmids for 48 h. The expressions of exogenous SLFN14 were determined by (A) real time qPCR and (B) western blot. Both representative figures and quantification data for western blot are shown. GAPDH was used as an internal reference. (C) Western blot analysis of SLFN14 protein expression in platelet lysates of the proband and two healthy subjects (control 1 and control 2). Both representative figures and quantification data are shown. (D) rRNA degradation in SLFN14-WT and SLFN14-T853fs) overexpressing HEK293T cells was assessed by denaturing agarose/formaldehyde gel electrophoresis (n = 3 independent experiments). (E) Cell proliferation of MEG-01 cells that were transfected by empty vector (EV), SLFN14-WT, or SLFN14-T853fs overexpression plasmids was determined by Cell Counting Kit-8 (CCK-8) assay. (F) Immunofluorescence staining against SLFN14 (red) of MEG-01 cells transfected with SLFN14-WT or SLFN14-T853fs overexpression plasmids for 48 h. Nuclei were counterstained with DAPI (blue). Merged images indicate the overlay of SLFN14 and nuclei signals. Images were captured using a 60× objective. Scale bars: 20 μm. Data are presented as mean ± standard deviation (SD). Comparisons between two groups were conducted using unpaired two-tailed Student’s t test.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.